The Metabolic Evaluation of the Patient with a Developmental Disorder
Abstract
Metabolic evaluation plays a critical role in the diagnosis and management of patients with developmental disorders. This process involves a thorough assessment of the patient’s medical history, physical examination, and a series of specialized laboratory tests. Key tests typically include blood and urine analyses to measure amino acids, organic acids, and other metabolic markers, alongside genetic testing to identify mutations linked to metabolic disorders. This chapter provides an in-depth examination of the metabolic evaluation process, detailing the tools used and the interpretation of the resulting metabolic profiles. Additionally, it explores the metabolic diseases most commonly associated with developmental disorders and emphasizes the importance of early detection. Identifying metabolic abnormalities early can lead to targeted interventions, such as dietary modifications, enzyme replacement therapies, and other medical treatments, which significantly improve clinical outcomes. In patients with developmental disorders, timely and accurate metabolic evaluation not only aids in diagnosis but also facilitates personalized treatment plans, ultimately improving quality of life and long-term prognosis.
Read the paper
Related studies
- Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
- Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
- Antioxidants, inflammation and cardiovascular disease
- Application of Metabolomics in Alzheimer’s Disease
- Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
- Nutritional essentiality of sulfur in health and disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.